More than five percent of new cancer cases occur in women of prepubescent and childbearing age. Which of the current cancer treatments specifically influence fertility? Are prepubescent women less vulnerable to the damaging effects of therapy? Dr. Clarisa Gracia, assistant professor of obstetrics and gynecology at the University of Pennsylvania School of Medicine, joins host Dr. Lisa Mazzullo to review methods to reduce and monitor the impact of chemotherapy or radiation on fertility.
Minimizing Cancer’s Impact on Fertility
Restart
Resume
Breast cancer - those are 2 words your patients do not want to hear and news that you do not want to deliver. Unfortunately, for 1 in 8 American women, it is a truth they will have to face in their lifetime and the risks are clear. Besides being female, the two major risk factors for developing breast cancer are advancing age and family history. In fact about 80% of women diagnosed with invasive breast cancer are age 50 and older, and while family history of the disease is an important risk factor
DICTATION ENDS ABRUPTLY.
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
More than five percent of new cancer cases occur in women of prepubescent and childbearing age. Which of the current cancer treatments specifically influence fertility? Are prepubescent women less vulnerable to the damaging effects of therapy? Dr. Clarisa Gracia, assistant professor of obstetrics and gynecology at the University of Pennsylvania School of Medicine, joins host Dr. Lisa Mazzullo to review methods to reduce and monitor the impact of chemotherapy or radiation on fertility.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
CME/CE
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
0.50 credits
<p>IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement</p>
CME/CE
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
0.25 credits
<p>IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis</p>
CME/CE Broadcast Replay
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
1.00 credits
<p>Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference</p>
CME/CE
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
1.00 credits
<p>Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies</p>
MinuteCE®
Diagnosis and Management of Metastatic PDAC
0.25 credits
<p>Diagnosis and Management of Metastatic PDAC</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
MinuteCE®
First-line Chemotherapy Options in Metastatic PDAC
0.25 credits
<p>First-line Chemotherapy Options in Metastatic PDAC</p>
MinuteCE®
Second-line Chemotherapy Options in Metastatic PDAC
0.25 credits
<p>Second-line Chemotherapy Options in Metastatic PDAC</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?